NCT07448363Not yet recruiting
Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
National Registry of Patients With Atopic Dermatitis Under Treatment With Dupilumab and JAK Inhibitors Within the Costa Rican Social Security System
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
The goal of this observational registry is to characterize the clinical features, severity, treatments, and outcomes of patients with atopic dermatitis in Costa Rica receiving systemic and advanced therapies in routine clinical practice. The main questions it aims to answer are: What are the demographic and clinical characteristics of patients with moderate-to-severe atopic dermatitis treated in specialized dermatology centers in Costa Rica? What treatments are used in real-world practice and how do they impact disease severity and patient-reported outcomes over time? Participants with atopic dermatitis receiving systemic or advanced therapies as part of their usual medical care will be followed longitudinally, with collection of clinical severity scores, treatment patterns, and outcomes during routine visits.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 26 Feb 2026
- Start date
- May 2026
- Primary completion date
- May 2031
- Lead sponsor
- Caja Costarricense de Seguro Social
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07448363
What you commit to
- Study type: Observational
- Planned participants: 50
- From May 2026 to the primary completion date, May 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Lack of sufficient clinical data for severity or treatment assessment
Who the study is looking for
- Clinical diagnosis of atopic dermatitis according to accepted diagnostic criteria
- Moderate-to-severe disease requiring systemic or advanced therapy
- Receiving systemic immunosuppressive, biologic, or other advanced treatment as part of routine care
- Evaluated in participating dermatology centers in Costa Rica
- Available clinical records with baseline and follow-up information
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Caja Costarricense del Seguro Social Coordinator of this site? Confirm its status | San José | Costa Rica | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.